Menopause Clinic London 2026: HRT, Testosterone and Bioidentical Hormones
Medically reviewed by The Online GP by The Wellness clinical team | Last updated: April 2026
A private menopause clinic in London 2026 typically charges £275 to £465 for initial specialist consultations and £150 to £195 for follow-up reviews, with body-identical HRT medication adding £10 to £35 per month at the pharmacy. The market has expanded rapidly because NHS access remains structurally inadequate: 10-minute GP appointments cannot deliver the depth of consultation menopause requires, NHS GPs are often unfamiliar with newer body-identical formulations, and testosterone for women remains contentious despite British Menopause Society support. At The Online GP by The Wellness in Marylebone, initial menopause specialist consultations are £295 for 45 minutes, follow-up reviews £195, comprehensive hormone blood panels £445, and ongoing prescription support including body-identical HRT and testosterone (AndroFeme) where clinically appropriate.
This guide explains exactly what perimenopause and menopause involve, what modern body-identical HRT looks like, why testosterone is increasingly prescribed for women, what to expect from a proper specialist consultation, and how London's private menopause market compares.
Speak to a GMC-registered doctor today: WhatsApp +44 7961 280835 | Email team@thewellnesslondon.com | Call 020 3951 3429
What is perimenopause and menopause?
Menopause is the point in a woman's life 12 months after her final menstrual period, marking the end of fertility and the permanent decline of ovarian hormone production. The average age of menopause in the UK is 51, but the range is 45 to 55. Premature menopause (before 40) and early menopause (40 to 45) affect approximately 1 in 100 and 1 in 20 women respectively.
Perimenopause is the transitional phase leading up to menopause, characterised by fluctuating hormone levels and emerging symptoms. It typically begins 4 to 10 years before final menstrual period, often in the early to mid 40s but sometimes from the late 30s. Perimenopause is when most women experience their most disruptive symptoms because hormone levels are not just declining but fluctuating wildly between high and low.
Postmenopause is the period after menopause has been confirmed (12 consecutive months without a menstrual period). Symptoms typically continue but often stabilise as hormone levels reach a consistent low baseline. Some symptoms (vaginal dryness, urinary issues, bone loss, cardiovascular risk changes) become more prominent in postmenopause.
The hormonal changes are substantial. Oestrogen affects over 400 body functions, with receptors in the brain, heart, blood vessels, bones, joints, skin, urinary tract, vagina, breast tissue, and many other systems. When oestrogen declines, every system with oestrogen receptors potentially experiences change. Progesterone declines first and most dramatically, often producing anxiety, sleep disturbance, and mood symptoms before any other changes. Testosterone in women (yes, women produce and need testosterone) declines gradually from the 30s onwards, contributing to fatigue, low libido, decreased energy, and reduced muscle mass.
Approximately 13 million UK women are currently perimenopausal or menopausal, with 1 in 4 considering leaving work due to severe symptoms (Department for Work and Pensions, 2022). The economic impact is substantial. The personal impact is devastating when symptoms are unrecognised, dismissed, or undertreated. Modern menopause care is fundamentally different from the limited, fearful approach that dominated after the 2002 Women's Health Initiative study (subsequently re-analysed and largely retracted in its original framing).
What are the symptoms of perimenopause and menopause?
The British Menopause Society recognises 34+ symptoms of perimenopause and menopause, far beyond the well-known hot flushes and night sweats. Many symptoms are misdiagnosed as anxiety, depression, ADHD, fibromyalgia, or chronic fatigue syndrome because clinicians unfamiliar with menopause do not connect the dots.
Vasomotor symptoms (hot flushes and night sweats) affect 75 to 80 percent of women and are the most recognised feature of menopause. Most women experience these for 4 to 7 years on average, though some experience them for 10+ years. They can range from mild warmth to drenching sweats requiring clothing changes. Night sweats disrupt sleep and contribute to daytime fatigue and cognitive symptoms.
Cognitive symptoms affect approximately 60 percent of women and are often the most distressing. Brain fog, word-finding difficulty, short-term memory problems, difficulty concentrating, and feelings of cognitive decline can be profound. Many women fear early dementia. The good news: these symptoms are typically reversible with appropriate hormone replacement.
Mood and mental health symptoms include anxiety (often new-onset or substantially worsened), low mood, irritability, rage and disproportionate emotional reactions, panic attacks, loss of confidence, and suicidal thoughts in severe cases. Hormonal mood symptoms are frequently misdiagnosed as primary depression or anxiety, leading to antidepressant prescribing without addressing the underlying hormonal driver.
Musculoskeletal symptoms include joint pain (especially hands, knees, hips), muscle aches, frozen shoulder (more common in perimenopause), stiffness, and decreased exercise recovery. Many women see rheumatologists for years before menopause is recognised as the underlying cause.
Cardiovascular symptoms include palpitations, increased heart rate at rest, blood pressure changes, and exercise intolerance. New-onset hypertension is common in the perimenopausal years.
Skin, hair, and connective tissue symptoms include skin dryness and itching, formication (crawling sensation on skin), hair thinning, brittle nails, increased facial hair (paradoxically), and accelerated skin ageing.
Genitourinary syndrome of menopause affects up to 80 percent of postmenopausal women and includes vaginal dryness, vulval thinning, painful intercourse, recurrent urinary tract infections, urinary frequency and urgency, and bladder leakage. These symptoms typically emerge later in perimenopause and worsen in postmenopause if untreated.
Sleep disturbance affects approximately 60 percent of perimenopausal women, with multiple mechanisms: night sweats, anxiety, hormonal fluctuation directly affecting sleep architecture, and increased sleep apnoea risk.
Less recognised symptoms include tinnitus, dizziness, taste changes, dry mouth, dry eyes, electric shock sensations, gum problems, increased food sensitivities, body odour changes, and altered libido.
The connection with ADHD is increasingly recognised. Oestrogen modulates dopamine and noradrenaline, two neurotransmitters central to ADHD. Many women with previously well-controlled or undiagnosed ADHD experience dramatic worsening during perimenopause, leading to diagnoses for the first time at age 40+. HRT often dramatically improves symptoms.
Speak to a menopause specialist about your symptoms: WhatsApp +44 7961 280835
What is body-identical HRT?
Body-identical HRT uses pharmaceutically-manufactured hormones with the same molecular structure as those produced naturally by the human body. This is the modern gold standard for hormone replacement, replacing the older synthetic preparations that drove most of the historic concerns about HRT safety.
The body-identical HRT regimen typically includes three components, prescribed individually based on your needs:
Oestrogen as transdermal oestradiol. Oestrogel (a pump dispenser of oestradiol gel applied to the skin daily) and Estradot or Lenzetto patches are the most common UK options. Transdermal delivery bypasses the liver, avoiding the increased blood clot risk associated with older oral oestrogens. Standard doses are 1 to 4 pumps daily of Oestrogel, or patches at 25 to 100 micrograms. Pricing at the pharmacy is typically £10 to £20 per month.
Progesterone as micronised progesterone (Utrogestan). This is bio-identical progesterone in oral capsule form, taken at night for women with a uterus to protect against endometrial overgrowth. Sometimes used vaginally for specific situations. Standard doses are 100mg nightly or 200mg cyclically. Pricing typically £15 to £25 per month.
Testosterone as 1 percent transdermal cream. AndroFeme is the body-identical testosterone cream most commonly prescribed for UK women. Tostran (a higher-strength gel licensed for men) is sometimes used at lower doses for women. Standard dose is 0.5g of AndroFeme daily applied to the lower abdomen or upper thigh. Pricing approximately £80 per 50g tube lasting 3 to 4 months.
Why body-identical HRT is preferred over synthetic options:
Reduced blood clot risk. Transdermal oestradiol does not increase venous thromboembolism (VTE) risk in most women, unlike oral oestrogens which approximately double VTE risk. This is critical for women with elevated baseline VTE risk including those over 60, with high BMI, or with personal or family history of clots.
Reduced breast cancer risk. The increased breast cancer risk attributed to HRT in the 2002 Women's Health Initiative study was largely driven by synthetic medroxyprogesterone acetate combined with conjugated equine oestrogen. Modern micronised progesterone with transdermal oestradiol carries minimal increased breast cancer risk, estimated at approximately 1 to 2 additional cases per 1,000 women over 5 years (compared with several additional cases per 1,000 with older preparations).
Better symptom control. Many women report better symptom relief with body-identical formulations than with older synthetic preparations, possibly due to molecular fit at hormone receptors.
Easier dose titration. Transdermal preparations allow precise dose adjustment by changing the number of pumps, patches, or strength, enabling individualised treatment.
What is the difference between body-identical and bioidentical HRT (BHRT)?
This is one of the most confused areas of menopause care. Body-identical HRT and Bioidentical Hormone Replacement Therapy (BHRT) sound similar but mean different things in regulated UK practice.
Body-identical HRT (the modern standard) uses MHRA-regulated, pharmaceutically-manufactured hormones with the same molecular structure as natural human hormones. Examples include Oestrogel, Utrogestan, AndroFeme, Estradot patches, Sandrena gel. These are regulated medicines with consistent dosing, quality control, evidence base, and safety data. The British Menopause Society endorses body-identical HRT as first-line treatment for most women.
Bioidentical Hormone Replacement Therapy (BHRT) in popular usage typically refers to compounded hormone preparations from specialist pharmacies, often custom-mixed based on individual prescriber preferences or saliva test results. These preparations are not MHRA-regulated as medicines and may have inconsistent dosing, no standardised quality control, no large-scale safety data, and often substantially higher cost.
The British Menopause Society position statement (2019, updated 2024) is clear: regulated body-identical HRT is the recommended approach. Compounded BHRT preparations should not be used routinely because of safety concerns, lack of regulation, and absence of evidence base.
The confusion arises because some clinics market body-identical HRT as "BHRT" or "bioidentical HRT" to attract patients seeking modern hormone replacement, when they are in fact prescribing regulated body-identical medications. This is not necessarily misleading but can confuse patients about what they are receiving.
At The Wellness, we prescribe regulated body-identical HRT as the standard approach: Oestrogel, Utrogestan, Estradot, Sandrena, AndroFeme, and other MHRA-regulated body-identical options. We do not routinely prescribe compounded BHRT preparations because the British Menopause Society does not recommend them.
If a clinic recommends compounded BHRT, ask:
Is the medication MHRA-regulated?
What is the evidence base?
What is the quality control?
Why would I choose this over regulated body-identical HRT?
If the answers are unclear or unsatisfactory, regulated body-identical HRT is almost always the safer and equally effective choice.
Can women have testosterone replacement?
Yes, and the British Menopause Society guidelines now actively support testosterone therapy for women with appropriate clinical indications. Testosterone for women remains an underprescribed treatment despite increasing evidence of benefit, partly because no testosterone preparation is currently MHRA-licensed for women in the UK (AndroFeme is licensed in Australia but used off-label in UK).
Why women need testosterone:
Women produce testosterone in their ovaries and adrenal glands, with levels approximately one-tenth of men's levels. Testosterone in women contributes to libido, energy, mood, cognitive function, muscle mass, bone density, cardiovascular health, and skin quality. Levels decline gradually from the 30s onwards, reaching approximately half of peak levels by age 50. Surgical menopause (removal of ovaries) causes immediate testosterone collapse alongside oestrogen and progesterone loss.
Indications for testosterone therapy in women:
Persistent low libido or hypoactive sexual desire disorder (HSDD) despite adequately replaced oestrogen is the strongest evidence-based indication, supported by NICE guidelines and BMS position statements. Many women with persistent libido issues on standard HRT respond dramatically to addition of testosterone.
Persistent fatigue and low energy despite optimised HRT is increasingly recognised as a testosterone-responsive symptom. While the evidence is less strong than for libido, clinical experience supports trial of testosterone in selected women.
Cognitive symptoms and brain fog that persist despite oestrogen replacement may respond to testosterone, though evidence remains emerging.
Mood symptoms not responding to standard HRT sometimes improve with testosterone, particularly motivation, drive, and assertiveness.
Reduced muscle mass and exercise capacity can improve with testosterone, particularly in women previously athletic who notice marked deterioration in postmenopause.
The standard prescribing approach in the UK:
AndroFeme cream at 0.5g daily applied to the lower abdomen or upper thigh, providing approximately 5mg testosterone (compared with male doses of 50 to 100mg). Cost approximately £80 per 50g tube lasting 3 to 4 months. Available through specialist pharmacies on private prescription.
Tostran gel (licensed for men) sometimes prescribed at very low doses (one-quarter of male starting dose) for women where AndroFeme is unavailable.
Monitoring includes baseline testosterone levels (total testosterone and free androgen index), repeat testing at 3 months to assess response and confirm levels remain in female physiological range, and annual monitoring. Side effects (acne, hair growth on application site, voice changes) are uncommon at appropriate female dosing but require monitoring.
NHS access to testosterone for women is currently limited and varies by region. Many NHS GPs are unfamiliar with prescribing or unwilling to prescribe due to off-label status. Private menopause specialists are the main route for most UK women seeking testosterone replacement.
Discuss testosterone for menopause with our specialist team: WhatsApp +44 7961 280835
How much does private menopause care cost in London?
Private menopause clinics in London charge £275 to £465 for initial consultations and £150 to £195 for follow-up reviews in 2026, with significant variation in service depth and specialist credentials between providers.
Medication costs at the pharmacy (paid separately to consultation fees):
Oestrogel pump: £10 to £20 per month depending on dose
Utrogestan capsules: £15 to £25 per month
Estradot patches: £10 to £15 per month
AndroFeme cream: £80 per 50g tube lasting 3 to 4 months (effectively £20 to £25 per month)
Sandrena gel: £15 to £25 per month
Vagifem or Vagirux pessaries: £10 to £20 per month for vaginal symptoms
Typical first-year cost for comprehensive private menopause care: approximately £700 to £1,200 including initial consultation, comprehensive blood testing, two follow-up reviews, and ongoing medication. Subsequent years typically £400 to £600 covering 1 to 2 reviews, repeat prescriptions, and medication.
Why proper specialist care justifies the cost:
The investment in proper menopause specialist care typically pays for itself many times over through:
Symptom resolution that NHS pathways often fail to deliver
Avoidance of inappropriate antidepressant prescribing (commonly given to women whose underlying issue is hormonal)
Long-term health protection including bone, cardiovascular, and cognitive benefits
Career and relationship preservation for women whose symptoms were threatening both
Quality of life improvement that is genuinely transformative for many women
NHS care remains valuable for many women, but where access is limited or symptoms are complex, private specialist care delivers the depth of consultation and comprehensive prescribing that menopause genuinely requires.
What does a menopause consultation at The Wellness include?
The initial menopause specialist consultation at The Online GP by The Wellness is 45 minutes and structured to deliver a complete assessment, evidence-based treatment plan, and immediate prescription where appropriate. Six elements distinguish a proper menopause consultation from a 10-minute NHS appointment.
1. Comprehensive symptom mapping. We use a structured menopause symptom questionnaire covering 30+ recognised symptoms across vasomotor, cognitive, mood, musculoskeletal, cardiovascular, genitourinary, and other domains. This baseline allows tracking of treatment response over time and ensures no symptoms are missed.
2. Detailed medical history. Personal medical history, surgical history, current medications, allergies, family history (particularly cardiovascular disease, stroke, blood clots, breast cancer, ovarian cancer, osteoporosis), reproductive history (cycle pattern, pregnancies, contraception history), and lifestyle factors (exercise, alcohol, smoking, sleep). This identifies any contraindications to specific HRT formulations.
3. Cardiovascular and bone risk assessment. Calculation of cardiovascular risk including blood pressure, cholesterol, family history; assessment of fracture risk including DEXA history if available; assessment of any neurological symptoms suggesting need for further investigation. These assessments inform HRT decisions.
4. Discussion of HRT options. We explain the full range of body-identical HRT options: which oestrogen formulation suits your circumstances (transdermal gel, patch, oral), which progesterone option (oral micronised progesterone, IUS, vaginal), whether testosterone is indicated, vaginal oestrogen for genitourinary symptoms, and non-hormonal alternatives where HRT is contraindicated.
5. Personalised treatment plan. Based on your symptom profile, history, and preferences, we develop a specific HRT regimen with starting doses, titration schedule, expected timeline for benefit, side effects to monitor, and review interval. The plan is documented and provided in writing.
6. Prescription and follow-up arrangement. Where HRT is appropriate, the prescription is written during the consultation (no separate fee) and dispensable at any UK pharmacy or our partner specialist pharmacy. Follow-up review at 3 months is scheduled to assess response. Direct WhatsApp access is available for any questions or concerns between appointments.
Comprehensive hormone blood panel (£445) is recommended for most patients to establish baseline values:
Oestradiol (E2)
FSH (follicle-stimulating hormone)
LH (luteinising hormone)
Progesterone (where cycle relevant)
Total testosterone
SHBG (sex hormone-binding globulin)
Free androgen index (calculated)
DHEA-S
Thyroid function (TSH, free T4, free T3)
Vitamin D, B12, folate, ferritin
Lipid profile
HbA1c
Liver and kidney function
Inflammatory markers
Blood testing is not always required to start HRT (FSH levels in perimenopause are unreliable due to fluctuation), but provides valuable baseline information particularly for testosterone titration and metabolic optimisation.
Frequently asked questions
What if I had a hysterectomy or oophorectomy?
Surgical menopause requires modified HRT approach. Hysterectomy alone (uterus removed, ovaries retained) eliminates the need for progesterone in HRT, allowing oestrogen-only replacement. Bilateral oophorectomy (ovaries removed) causes immediate complete menopause regardless of age and typically requires more aggressive HRT replacement, often including testosterone, with treatment continued at least until natural menopausal age (51).
Can I have HRT after breast cancer?
Standard HRT is generally avoided after breast cancer due to oestrogen receptor concerns. Specific situations may permit limited use of HRT (vaginal oestrogen for severe genitourinary symptoms, HRT after long disease-free interval, hormone receptor-negative cancers) but require specialist input from oncology and menopause specialist together. Non-hormonal symptom management options exist and should be explored first. Decisions are individualised.
What about HRT after blood clots?
Personal history of unprovoked blood clots is generally a contraindication to oral HRT but transdermal HRT (oestradiol patches or gel) does not increase blood clot risk and may be acceptable after specialist assessment. Family history of clots warrants genetic thrombophilia screening before starting any HRT.
Can I get pregnant in perimenopause?
Yes. Fertility declines but does not disappear during perimenopause. Contraception is recommended until 12 months after final menstrual period if menopause occurs after 50, or 24 months after if menopause occurs before 50. HRT itself does not provide contraception. Discuss contraception during your menopause consultation if relevant.
Will HRT make me put on weight?
No. HRT does not directly cause weight gain. Many women gain weight during perimenopause due to age-related metabolic changes, decreased muscle mass, and lifestyle factors. HRT often improves body composition by maintaining muscle mass, supporting motivation for exercise, and improving sleep quality (poor sleep drives weight gain). Some women find their weight stabilises or improves on HRT.
Are saliva tests for hormone levels accurate?
Saliva hormone tests are not validated for guiding HRT prescribing in mainstream menopause medicine. The British Menopause Society and Royal College of Obstetricians and Gynaecologists do not recommend saliva testing for menopause assessment. Where blood testing is needed, venous blood samples processed at accredited laboratories provide reliable results. Treatment decisions are typically based on symptoms rather than blood levels.
Can I see a menopause specialist via video consultation?
Yes. The Wellness offers menopause specialist consultations via video for patients unable to attend in person. The clinical assessment is equivalent except where physical examination is needed (typically for genitourinary symptom assessment). Video consultations are particularly suitable for international patients, those outside London, or patients preferring the privacy of home consultation.
Book your menopause consultation today
If you are struggling with perimenopause or menopause symptoms, you do not have to navigate this alone or wait years for NHS specialist input. The Online GP by The Wellness offers same-day specialist consultations at our Marylebone clinic and via video, with GMC-registered doctors aligned with British Menopause Society guidance, body-identical HRT including testosterone where appropriate, comprehensive blood testing, and continuity of care.
Three ways to book today:
WhatsApp: Message +44 7961 280835 for a same-day reply from our medical team. Tell us your symptoms and questions.
Email: team@thewellnesslondon.com for detailed enquiries, complex history discussion, or international patient queries.
Phone: 020 3951 3429 to speak directly to our team during clinic hours.
The Wellness, 10 Portman Square, Marylebone, London W1H 6AZ. Two minutes from Baker Street. Adjacent to Harley Street. GMC-registered doctors. Initial menopause specialist consultation £295. Body-identical HRT and testosterone where appropriate. The menopause care women actually need.
References and further reading
British Menopause Society guidelines and position statements, thebms.org.uk
NICE NG23 (Menopause: diagnosis and management)
Royal College of Obstetricians and Gynaecologists guidance on menopause
International Menopause Society 2023 recommendations
Re-analysis of the Women's Health Initiative study findings
NICE TA evidence on bioidentical HRT and compounded preparations
MHRA guidance on regulated body-identical hormone preparations
British National Formulary entries for Oestrogel, Utrogestan, AndroFeme, Estradot
Faculty of Sexual and Reproductive Healthcare guidance on menopause and contraception
Department for Work and Pensions data on menopause and work participation
Disclaimer: This article is for educational purposes only and does not constitute medical advice. HRT decisions are individualised based on personal medical history, symptoms, and preferences after consultation with a qualified specialist. The Wellness is a private healthcare clinic with GMC-registered doctors. We prescribe regulated body-identical HRT in line with British Menopause Society guidance.